This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

"V体育官网入口" Your saved search

Name of saved search: \/]*" title="The following characters are not allowed in the Name field: "&=<>/">

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Full text links

Full text links

V体育官网入口 - Actions

. 2014 Dec;44(6):1697-700.

doi: 10.1183/09031936.00162414. Epub 2014 Oct 16.

Eosinophilic inflammation in COPD: prevalence and clinical characteristics

Dave Singh¹, Umme Kolsum², Chris E Brightling³, Nicholas Locantore⁴, Alvar Agusti⁵, Ruth Tal-Singer⁶; ECLIPSE investigators

Affiliations

Affiliations

¹ University of Manchester, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, Manchester, UK.
² University of Manchester, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, Manchester, UK ukolsum@qiuluzeuv.cn.
³ Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
⁴ GlaxoSmithKline, Research and Development, Research Triangle Park, NC, USA.
⁵ Fundació Investigació Sanitària Illes Balears (FISIB), Centro de investigación biomedical en red de enfermedades respiratorias (CIBERES), Palma de Mallorca, Spain.
⁶ GlaxoSmithKline, Research and Development, King of Prussia, PA, USA.

PMID: 25323230
DOI: "V体育官网入口" 10.1183/09031936.00162414

Free article

Eosinophilic inflammation in COPD: prevalence and clinical characteristics (V体育平台登录)

Dave Singh et al. Eur Respir J. 2014 Dec.

Free article

. 2014 Dec;44(6):1697-700.

doi: 10.1183/09031936.00162414. Epub 2014 Oct 16.

"VSports最新版本" Authors

Dave Singh¹, Umme Kolsum², Chris E Brightling³, Nicholas Locantore⁴, Alvar Agusti⁵, Ruth Tal-Singer⁶; ECLIPSE investigators

Affiliations (VSports在线直播)

¹ University of Manchester, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, Manchester, UK.
² University of Manchester, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, Manchester, UK ukolsum@qiuluzeuv.cn.
³ Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
⁴ GlaxoSmithKline, Research and Development, Research Triangle Park, NC, USA.
⁵ Fundació Investigació Sanitària Illes Balears (FISIB), Centro de investigación biomedical en red de enfermedades respiratorias (CIBERES), Palma de Mallorca, Spain.
⁶ GlaxoSmithKline, Research and Development, King of Prussia, PA, USA.

PMID: 25323230
DOI: 10.1183/09031936.00162414

No abstract available

PubMed Disclaimer

VSports - Publication types

Actions (V体育官网入口)
Actions

VSports注册入口 - MeSH terms

Actions (V体育官网入口)
Actions (VSports)
Actions
Actions (V体育2025版)
Actions
V体育2025版 - Actions
Actions
Actions
VSports - Actions
"V体育平台登录" Actions
Actions (VSports最新版本)
Actions
VSports - Actions
Actions

Associated data

"VSports" Actions
- Search in PubMed
- Search in ClinicalTrials.gov

Grants and funding

G0601369/MRC_/Medical Research Council/United Kingdom

"VSports注册入口" LinkOut - more resources

Full Text Sources (V体育安卓版)
- HighWire
Other Literature Sources
- "VSports手机版" The Lens - Patent Citations Database
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information